Nicholas Lydon (Q547551)

From Wikidata
Jump to navigation Jump to search
British biochemist
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    Nicholas Lydon
    British biochemist

      Statements

      image
      Nicholas Lydon.jpg
      2,400 × 3,613; 491 KB
      point in time
      14 April 2005
      0 references
      occupation
      biochemist
      0 references
      chemist
      0 references
      researcher
      0 references
      award received
      Japan Prize
      point in time
      2012
      0 references
      Lasker-DeBakey Clinical Medical Research Award
      point in time
      2009
      award rationale
      For the development of molecularly-targeted treatments for chronic myeloid leukemia, converting a fatal cancer into a manageable chronic condition. (English)
      1 reference
      reference URL
      https://laskerfoundation.org/winners/molecularly-targeted-treatments-for-chronic-myeloid-leukemia/
      Warren Alpert Foundation Prize
      point in time
      2000
      award rationale
      For development of Abl kinase inhibitors for use in the treatment of chronic myelogenous leukemia. (English)
      1 reference
      reference URL
      https://warrenalpert.org/prize-recipients/nicholas-lydon
      Clarivate Citation Laureates
      point in time
      2011
      field of work
      medicine
      award rationale
      "for their development of imatinib and dasatinib, revolutionary, targeted treatments for chronic myeloid leukemia." (English)
      1 reference
      reference URL
      https://clarivate.com/citation-laureates
      retrieved
      23 September 2023

      Identifiers

      Prabook ID
      1444913
      0 references
       
      edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q547551&oldid=2233445917"